‘If, Then’…. Amgen Could Recover Much More (AMGN, BIIB)
Amgen (NASDAQ:AMGN) has seen a slight recovery of late, mostly on reports that the U.S. Senate is asking Centers for Medicaid and Medicare Services to reconsider the drastically cut reimbursement ...Read Full Story »

